Title
Safety of the APOLLO Onyx delivery microcatheter for embolization of brain arteriovenous malformations: results from a prospective post-market study.
Document Type
Article
Publication Date
2-1-2021
Publication Title
J Neurointerv Surg
Keywords
oregon; portland
Abstract
BACKGROUND: Catheter retention and difficulty in retrieval have been observed during embolization of brain arteriovenous malformations (bAVMs) with the Onyx liquid embolic system (Onyx). The Apollo Onyx delivery microcatheter (Apollo) is a single lumen catheter designed for controlled delivery of Onyx into the neurovasculature, with a detachable distal tip to aid catheter retrieval. This study evaluates the safety of the Apollo for delivery of Onyx during embolization of bAVMs.
METHODS: This was a prospective, non-randomized, single-arm, multicenter, post-market study of patients with a bAVM who underwent Onyx embolization with the Apollo between May 2015 and February 2018. The primary endpoint was any catheter-related adverse event (AE) at 30 days, such as unintentional tip detachment or malfunction with clinical sequelae, or retained catheter. Procedure-related AEs (untoward medical occurrence, disease, injury, or clinical signs) and serious AEs (life threatening illness or injury, permanent physiological impairment, hospitalization, or requiring intervention) were also recorded.
RESULTS: A total of 112 patients were enrolled (mean age 44.1±17.6 years, 56.3% men), and 201 Apollo devices were used in 142 embolization procedures. The mean Spetzler-Martin grade was 2.38. The primary endpoint was not observed (0/112, 0%). The catheter tip detached during 83 (58.5%) procedures, of which 2 (2.4%) were unintentional and did not result in clinical sequelae. At 30 days, procedure related AEs occurred in 26 (23.2%) patients, and procedure-related serious AEs in 12 (10.7%). At 12 months, there were 3 (2.7%) mortalities, including 2 (1.8%) neurological deaths, none of which were device-related.
CONCLUSION: This study demonstrates the safety of Apollo for Onyx embolization of bAVMs.
CLINICAL TRIAL REGISTRATION: CNCT02378883.
Clinical Institute
Neurosciences (Brain & Spine)
Department
Neurosciences
Recommended Citation
Meyers, Philip M; Fifi, Johanna T; Cockroft, Kevin M; Miller, Timothy R; Given, Curtis A; Zomorodi, Ali R; Jagadeesan, Bharathi D; Mokin, Maxim; Kan, Peter; Yao, Tom L; Diaz, Orlando; Huddle, Daniel; Bellon, Richard J; Seinfeld, Joshua; Polifka, Adam J; Fiorella, David; Chitale, Rohan V; Kvamme, Peter; Morrow, Jay T; Singer, Justin; Wakhloo, Ajay K; Puri, Ajit S; Deshmukh, Vivek; Hanel, Ricardo A; Gonzalez, L Fernando; Woo, Henry H; and Aziz-Sultan, Mohammad Ali, "Safety of the APOLLO Onyx delivery microcatheter for embolization of brain arteriovenous malformations: results from a prospective post-market study." (2021). Articles, Abstracts, and Reports. 4477.
https://digitalcommons.providence.org/publications/4477
